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Abstract
The focus of a survival study is partly on the distribution of survival times,
and partly on the health or quality of life of patients while they live. Health
varies over time, and survival is the most basic aspect of health, so the two
aspects are closely intertwined. Depending on the nature of the study, a
range of variables may be measured; some constant in time, others not; some
regarded as responses, others as explanatory risk factors; some directly and
personally health-related, others less directly so. This paper begins by clas-
sifying variables that may arise in such a setting, emphasizing in particular,
the mathematical distinction between vital and non-vital variables. We ex-
amine also various types of probabilistic relationships that may exist among
variables. Independent evolution is an asymmetric relation, which is intended
to encapsulate the notion of one process driving the other; X is a driver of Y
if X evolves independently of the history of Y . This concept arises in several
places in the study of survival processes.
1 Introduction
This paper is concerned with survival times and health monitoring, meaning math-
ematical models for the distribution of survival times and health-related processes.
Health monitoring is interpreted broadly to include the measurement of any vari-
able that might be deemed relevant to individual health. Obvious examples include
(i) blood serum level, (ii) pulse rate, (iii) quality of life in a geriatric study, or
(iv) physical dexterity or mental acuity. Less obvious examples include (v) the
value of the patient’s retirement portfolio, (vi) the ambient temperature or ozone
level as a measure of health threat, or (vii) the patient’s schedule of medical ap-
pointments. An intermediate example is (viii) the type of care facility or retirement
home. The focus is on situations where mortality is appreciable, so geriatric studies
feature prominently in examples.
Mathematically speaking, a variable Y is a function of time, so that Yi(t) is the
value for patient i at time t ≥ 0, measured relative to a suitable temporal origin,
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usually recruitment. If Ti > 0 is the survival time for patient i, the re-coded variable
T˜i(t) =
{
1 t < Ti
0 otherwise,
is a function of time, defined for all t ≥ 0. As the re-coded survival process illus-
trates, every variable Y is defined for all t ≥ 0, including t > Ti.
In some contexts such as the retirement portfolio or the ozone pollution level, the
definition for t > Ti poses no physical or conceptual difficulty; the process evolves
after death and values can be recorded with little additional inconvenience. If the
portfolio has been liquidated or dispersed, the value is zero. In other instances
where it is not feasible to measure the pulse rate or quality of life without detecting
that the patient is no longer alive, it is necessary to include in the state space a
special value indicating that the patient is dead. Death is presumed to be a fatal
event, so that this special value is an absorbing state. For example, T˜i(t) = 0 is the
absorbing state for survival.
2 Vital and non-vital variables
Let Yi ≡ (Yi(s))s≥0 be the entire temporal trajectory of the variable Y for patient i,
and let Ti > 0 be the survival time. The variable Y is said to be vital if the single
value Yi(t) suffices to determine whether or not patient i is alive at time t. In other
words, Y is vital if, for each t ≥ 0, the conditional probability satisfies
pr(Ti > t | Y ) = pr(Ti > t | Yi(t)) ∈ {0, 1}. (1)
The first part of the condition asserts that the event Ti > t is conditionally indepen-
dent of Y given Yi(t), so the single value Yi(t) suffices to determine the conditional
probability. The second part says that the conditional probability is either zero or
one, i.e., no intermediate values are allowed. Otherwise, if the present value alone
is not sufficient, or if the conditional probability lies in (0, 1) for some t, we say that
Y is non-vital.
For survival studies, the distinction between vital and non-vital variables is
fundamental. It is immediately apparent that the re-coded survival time T˜ is vital.
In addition, if Y is vital, and Z is any other variable defined concurrently, the pair
(Y, Z) is also vital. Likewise, if Z is real or vector-valued with no atom at zero,
the product T˜Z is vital. Thus, a vital variable may contain components that are
non-vital, irrelevant, or even trivial.
A vital variable that is constant post mortem is called purely vital. It has one
or more absorbing states, each representing death, but perhaps associated with
different causes.
A variable that is constant in time cannot be vital. Generally speaking, a mea-
surement of a specific bodily function such as pulse rate, mental acuity, blood serum
level or forced expiratory volume is vital. Likewise, any variable such as weight or
body temperature, which cannot be measured without detecting whether the pa-
tient is alive, is a vital variable. Age is personal but not vital. Other personal
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variables of a financial nature may not be vital, and non-personal variables, even if
they are health-related, are usually not vital.
Kalbfleisch and Prentice (2002, §6.3) discuss various aspects of time-dependent
processes and their use as covariates in survival analysis. Their definition of an
external variable coincides with an exogenous variable as defined below; their defi-
nition of an internal variable (not external) is not the same as a vital variable, but
the motivation is similar. A variable may be neither vital nor external.
3 Independent evolution
Vitality is a property of a variable in isolation. Independence is a property of a pair
of variables or a set of variables. For variables in the sense of temporal processes,
independence is a very strong property seldom satisfied by any pair in medical
work. For example, the death rate in certain cities is affected by the weather, both
extreme cold and extreme heat being contributing factors, so survival time is not
independent of the outside air temperature. However, a weaker, and arguably more
relevant, condition may be satisfied such that the weather evolves independently of
the death rate.
Let X,Y be two continuous-time stochastic processes, and let HXYt = H
X
t ⊗H
Y
t
be the σ-field generated by all past values (Xs, Ys)0≤s≤t. The temporal evolution
of Y is governed by its transition probabilities, or, more generally, by conditional
probabilities of the type pr(Y ∈ A | HYt ) for various future events A. The temporal
evolution of the pair is also governed by conditional probabilities pr((Y,X) ∈ A×B |
HXYt ), and if we choose B to be the entire X-space, the conditional probability
becomes pr(Y ∈ A | HXYt ). By definition, the average value of pr(Y ∈ A | H
XY
t ),
averaged over past X-values, is equal to pr(Y ∈ A | HYt ). If, however, H
Y
t is
sufficient to determine the conditional probabilities, i.e., if
pr(Y ∈ A | HXYt ) = pr(Y ∈ A | H
Y
t ), (2)
for each event A, then the subsequent trajectory of Y is independent of past X-
values. In the symbolism of Dawid (1979),
Y ⊥ HXt | H
Y
t
for every t, and we say that Y evolves independently of HX .
Independent evolution captures a certain asymmetric relation between two tem-
poral processes. Roughly speaking, the death rate Y is not independent of the
weather,X , but the weather evolves independently of the death rateX ⊥ HYt | H
X
t .
Conversely, the conditional hazard or death rate at time t given the entire weather
trajectory depends only on current and past values, not on future weather patterns,
so the death rate is driven by current and past weather patterns. (This is a natural
mathematical assumption, not a meteorological fact.) In such cases, we say that
the weather is statistically exogenous for the response (Robins, 1999), or external
in the sense of Kalbfleisch and Prentice (2002, p. 196).
In a similar manner with roles reversed, the frequency of medical monitoring
may depend explicitly on disease severity, but the disease evolution may, in certain
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circumstances, be independent of the configuration of past monitoring times. Con-
versely, the monitoring rate is driven by the disease history. In the first example,
the external variable evolves independently of disease and death; in the second,
the disease evolves independently of monitoring activity (on the presumption that
monitoring is passive or that the disease is incurable, and no intervention is feasi-
ble). The terms optional sampling, sequential sampling, and optional stopping are
frequently used in this setting (Dawid, 1979).
Most examples of external processes are also ancillary, in the sense that their
distribution is independent of the parameters of interest. These two concepts are
mathematically unrelated. Independent evolution is a probabilistic property of each
process individually. Ancillarity is a distributional property of the parameterized
set of processes in the model, not a property of individual processes.
Independent evolution is a strong property of the joint distribution, but it is not
nearly so strong as complete independence. Unlike independence, it is an asymmet-
ric relationship; if Y evolves independently of X , then X does not usually evolve
independently of Y . On the other hand, if Y evolves independently of X , and
X also evolves independently of Y , it is natural to ask whether the two processes
are independent. The answer is negative, but they are conditionally independent
given the initial value (X0, Y0).
In the preceding discussion HXYt is the σ-field generated by all values occurring
at or before time t. More generally, the sequence (HXYt )t≥0 is a filtration generated
by some, but not necessarily all, past values, and condition (2) states that Y is
independent of HXt given H
Y
t . For example, H
XY
t could be the σ-field generated by
the random variables (Xs, Ys) for integer times s ≤ t. In that case, Y ⊥ H
X
t | H
Y
t
is a statement not only about the subsequent evolution of Y , but also about values
at earlier non-integer time points. The same statement interpreted in reverse says
that the conditional probability of each event in HXt given Y depends only on those
past values that are included in HYt .
4 Joint models
Let X be a variable in the sense of a temporal stochastic process, and let T be
the survival time. The term joint model refers to the joint distribution of the
pair (X,T ), or equivalently, the pair (X, T˜ ). If X is vital, the joint distribution is
degenerate, and nothing further needs to be said. Hence, without loss of generality,
we assume that X is non-vital. The literature on joint models is very extensive,
and no attempt is made here to review it. For an overview, see Henderson Diggle
and Dobson (2000), Tsiatis and Davidian (2004) or Rizopoulos (2012).
The mathematical strategy most commonly employed for the construction of a
joint process begins with an unobservable, or latent, process η such that T ⊥ X | η.
For purposes of illustration, if X is a real-valued process, we may choose η to be a
zero-mean Gaussian process with covariance function K, followed by
X(t) = η(t) + ǫ(t)
4
− log pr(T > t | η) =
∫ t
0
h(η(s)) ds, (3)
where ǫ(t) is white-noise measurement error, and h(η(t)) ≥ 0 is the conditional
hazard function given η. This construction ensures that η evolves independently of
(X, T˜ ), and that T and X are not independent.
The conditional distribution of η given X is Gaussian
η | X ∼ N(K(I +K)−1X, K(I +K)−1)
with conditional mean linear in X . The conditional survivor function given X
pr(T > t | X) =E
(
exp
(
−
∫ t
0
h(η(s)) dx
) ∣∣∣ X
)
(4)
reduces to a Gaussian integral, albeit infinite-dimensional. For any given covariance
function, it is easy to check numerically whether the conditions for independent
evolution of X and T˜ are satisfied, for example, by checking whether the conditional
survivor function (10) is or is not independent of future X-values. It is possible that
the independent-evolution condition may be satisfied by certain special covariance
functions or by special choice of parameters in (3), but no such parameters are
known apart from degeneracies such as ǫ(t) = 0 for all t. In general, it appears
that the conditional survivor function depends not only on past X-values, but also
on future X-values. In other words, the process X is neither vital nor statistically
exogenous.
In the literature on joint models, the latent process is commonly referred to as
the patient’s ‘true state of health’. In fact, (3) implies that η satisfies neither of
the conditions for vitality, so the ‘true state of health’ at time t is not sufficient to
determine the most basic vital fact—whether or not the patient is alive. Among
the eight variables X listed as examples in section 1, five are naturally regarded as
vital. A further two are presumed to satisfy the independent-evolution condition,
one example forX ⊥ HYt | H
X
t and one for Y ⊥ H
X
t | H
Y
t , with Y = T˜ . That leaves
only one candidate—the value of the patient’s retirement portfolio—as a plausible
example of a variable that satisfies neither condition.
If Y were a time-evolving risk factor such as the measured ozone pollution level,
a reasonable case might be made that η(·) is the ‘true pollution level’. That usage is
in keeping with Besag and Higdon (1999). Its justification rests on the presumption
that the true pollution level varies in time as prescribed by K, usually continuously,
so that any white-noise component in Y must be associated with pure measurement
error. Even in that situation, it is not easy to rationalize the dependence of the
conditional survivor function pr(T > t | Y ) on future measured pollution levels
unless each cadaver contributes subsequently to pollution or to measurement error.
5 Stochastic specification
Let Y be a vital variable, i.e., a stochastic process in continuous time with state
space S, and let T > 0 be the survival time. It is always possible to recode T as
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a Boolean process and to include it as a component in Y , so there is no loss of
generality in the restriction to vital variables.
In order to specify the joint distribution of Y , it is necessary and sufficient to
specify, for each finite collection of ordered time points t = (t1 < · · · < tk), the joint
distribution Pt(·) of the values (Yt1 , . . . , Ytk) in S
k. These joint distributions are
subject to the standard Kolmogorov consistency conditions for a stochastic process.
The density function relative to a suitable product measure in Sk is denoted by
pt(y).
Although these finite-dimensional distributions are sufficient to determine the
joint distribution of the process, it is sometimes helpful to specify the same distri-
bution in an alternative manner. We may ask for the joint distribution Qt(·, dt) of
the values (Yt1 , . . . , Ytk) together with the survival time T > 0, in S
k ×ℜ+. These
distributions are also subject to Kolmogorov consistency conditions. In addition
Pt(A) = Qt(A×ℜ
+) =
∫ ∞
0
Qt(A, dt),
for arbitrary events A ⊂ Sk, so the mapping from Q to P is a one-dimensional
integral over survival times.
The joint distribution Qt also determines the clinical predictive distribution
pr(T ∈ dt | (y, t)) = qt(y, dt)/pt(y)
of the survival time given the finite sequence of values y = (y1, . . . , yk) occurring at
earlier appointment times t1, . . . , tk. Ordinarily, the patient is alive at time tk, so the
conditional distribution is supported on (tk,∞). The clinical predictive distribution
is not to be confused with the conditional distribution given the past history up to
time tk = max(t) because the latter is a function of the entire trajectory, which is
seldom observed in a clinical setting.
6 Sampling distributions
A point process on the real line may be sampled by counting events in a fixed
domain, or by measuring inter-arrival times for a fixed number of events. The
two sampling distributions are of a different nature on different spaces, but they are
mutually consistent, equivalent, and they are both determined by the point process.
Likewise, in a survival study, the values may be acquired in more than one way,
and it is necessary to describe the sampling protocol before the sample space and
the sampling distribution can be specified. In particular, the processes are defined
continuously in time, but seldom observed continuously. In addition, values of non-
vital variables may be recorded post mortem, but this is rarely done because such
values would seldom be considered relevant to the objectives of the study.
We consider first the simplest data-acquisition scheme in which measurements
are made on an arbitrary schedule, specified at the time of recruitment, for a fixed
period L comprising k measurement times, which are not necessarily the same for
each patient. If, however, the patient dies before the end of the observation period,
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the time of death is also recorded. The sample space for this scheme is the disjoint
union Sk ∪ (Sk × (0, L)). The probability density is pt(y) at y in S
k plus qt(y, t) on
the product space Sk × (0, L).
The presumption here—that measurement continues post mortem—is not nec-
essarily realistic, but the implications are worth pursuing. First, if Y is a purely
vital process with a single absorbing state, the post-mortem value is fixed and un-
informative, so it is immaterial whether the value is explicitly recorded. Second, if
Y is purely vital with multiple absorbing states, the post-mortem value is a random
constant, which could be informative for cause of death. A typical health trajectory
prior to accidental death might be quite different than the a typical trajectory prior
to death from leukaemia.
The more interesting case is one in which Y = (Y0, Y1), where Y0 is purely vital
and Y1 is non-vital. For example Y1 might be a time-evolving risk factor. If Y1
evolves independently of Y0 given the history of both, the post-mortem evolution
of Y1 is independent of the vital history, and it can reasonably be argued on that
contextual basis that the post-mortem evolution is not relevant for patient health.
On the other hand, if Y1 does not evolve independently of Y0, this argument no
longer applies, and the subsequent values do affect the likelihood. For example,
the irrelevance argument does not apply to joint models using the construction in
section 4.
For the second data-acquisition scheme, the sampling times t = (t0 < t1 < · · ·)
are chosen randomly with t0 = 0 in such a way that Y evolves independently of X
given the observed history. Here, X(tj) = tj+1 is the sequence of sampling times
recorded as a ca`dla`g step function. The first observed value is a pair (Y (t0), t1), the
next value (Y (t1), t2) occurs at time t1 > 0, followed by (Y (t2), t3) at time t2 > t1,
and so on, so HXYt is the σ-field generated by the variables (Y (tj), tj+1) for tj ≤ t.
Sampling terminates at a fixed time L or at death, whichever comes first. If death
occurs, the time is recorded. This procedure gives rise to a sequence of times t of
random length, and a sequence of values y ∈ S#t−1, one value for each sampling
time except for the last. The independent-evolution condition implies
pr(Y ∈ A | HXYt ) = pr(Y ∈ A | H
Y
t )
for every event A. This is equivalent to the condition that the distribution of tj+1
given Y is a function of previous observed values only, i.e., a function of t0, . . . , tj and
Yt0 , . . . , Ytj , which is the sequential conditional independence condition of Dempsey
and McCullagh (2016).
A consequence of the independent-evolution condition is that the joint density
of the times and values is either
pt(y)×
∏
j≥0
p(tj+1 | H
XY
tj ) (5)
if no failure occurs, or
qt(y, t)×
∏
j≥0
p(tj+1 | H
XY
tj ) (6)
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if failure occurs at time t ≤ L. In this setting, p(s | HXYt ) is the conditional density
at s > t of the next scheduled appointment given the observed values up to time t.
Note that #t is a random variable whose distribution is not independent of Y .
An important aspect of the preceding derivation is that the next appointment
time is scheduled and recorded at the previous appointment, so every off-schedule
appointment is detectable, and is a breach of protocol.
7 Likelihood function
Consider now a family of probability distributions indexed by θ ∈ Θ for a vital pro-
cess Y , which is sampled according to one of the schemes described in the preceding
section. The joint density of the Y -values at a fixed configuration t of sampling
occasions is pt(y; θ). The joint density of values and survival time is qt(y, t; θ), so
that pt(y; θ) =
∫∞
0
qt(y, t; θ) dt.
The second factor in (5) is a probability distribution determined entirely by the
experimental protocol. In other words, the second factor is parameter-free and does
not contribute to the likelihood function. Although the sample space and the sam-
pling distribution depend heavily on the sampling scheme, the likelihood function
for the second data-acquisition scheme is the same as if the sampling times were
fixed in advance. The independent-evolution assumption is essential for this con-
clusion, so all off-schedule appointments should be noted and treated with caution.
For an instance of this, see Liestøl and Anderson (2002).
On the assumption that processes for distinct patients are independent, the
likelihood function is the product over patients, each censored record contributing
a factor pt(y; θ), each uncensored record contributing qt(y, t; θ). Of course, the
values (t, y) or (t, y, t) are patient-specific, and the sequence lengths #t also vary
from one patient to another, even in a setting where the responses for distinct
patients are identically distributed.
In the presence of covariates such as age or treatment, the response distributions
for two patients having different x-values may be different. Denote the response
density at y and (y, t) for one patient with covariate x by pt(y;x, θ) and qt(y, t;x, θ)
respectively. Then the likelihood function function is a product of these factors,
one density term for each patient.
8 A Gaussian survival process
8.1 Background
Up to this point, the emphasis has been on general principles, no attempt being
made to construct specific survival processes for use in applications. We consider
now an example of a survival process of the simplest type, one in which Y is a
purely vital variable with state space S = ℜ ∪ {♭}; either Yi(t) is a real number, in
which case patient i is alive at time t, or Yi(t) = ♭ in which case the patient is dead
at time t. In this setting, where post-mortem values are fixed and non-random, it
is immaterial which of the two sampling schemes described in section 6 is used. For
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the second scheme, the assumption that Y evolve independently of the scheduled
appointment times is crucial. Initially, for simplicity, it is assumed that there are no
covariates, so the observations for distinct patients are independent with the same
distribution.
We first derive the joint density function qt(y, t) for the values and the survival
time. Let the survival density be f . Let the conditional distribution of Y given
T = t be Gaussian on the interval [0, t) with conditional moments
E(Ys | T = t) = µt(s)
cov(Ys, Ys′ | T = t) =Kt(s, s
′)
for 0 ≤ s, s′ < t. The conditional covariance function is necessarily positive definite,
but the specification is otherwise unrestricted. On the assumption that T <∞ with
probability one, Dempsey and McCullagh (2016) use a family of conditional mean
functions
µt(s) = α(t) +m(t− s), (7)
which is an additive function of the survival time t and the revival time t− s. Here,
m(·) is the characteristic mean curve of the process in revival time. Additivity on
this scale was found to be much more effective than additivity in t and s.
In practice, the conditional covariance function must include an additive random
constant for each patient, a non-trivial temporal process for each patient and a
white noise term independent for each patient and each time. The first two should
be independent and identically distributed for each patient. Other covariance terms
may also be needed, depending on the context.
If the design includes a treatment effect, the survival process for the active
treatment levels may be different in distribution from the the control process. To
accommodate the effect of treatment on the health process, the additive model may
be modified so that the conditional mean given T = t for a patient with treatment
level x is
µt(s) = α(t) +mx(t− s).
Additivity is retained, but the characteristic mean curve depends on the treatment
arm, the simplest version being mx(t−s) = m0(t−s)+βx, so that the mean curves
are parallel in revival time. Given two patients, one surviving for three years with
x1 = 1 and one for five years with x2 = 2, the conditional means at time ti − z,
i.e., z years prior to failure are
µ3(3− z) =m0(3) +m1(z),
µ5(5− z) =m0(5) +m2(z)
respectively. Note that µ3(s) is not defined for s ≥ 3, so it is not possible to compare
conditional means at arbitrary fixed times, but it is possible to compare them for
arbitrary fixed revival time t−s, as indicated here. The difference µ5(5−z)−µ3(3−z)
is a sum of two parts, one related to the effect of the differing survival times, and
the second, m1(z)−m2(z), associated with the effect of treatment on the patients’
health while they are alive. The function µt(t − z) is defined for all t, z > 0, but
only z ≤ t is typically needed.
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It is important to bear in mind that the first component Yi(0) is measured at
recruitment, and that, modulo covariate information, all patients are on an equal
footing at this point. More generally, xi = xj implies that Yi(0) ∼ Yj(0) have the
same distribution regardless of the treatment arm to which they are subsequently
assigned. Thus, treatment is a time-varying function whose value xi(s) is constant
for s > 0, but xi(0) = xj(0) is the same null level for every patient.
In the following description, t ⊂ [0,∞) is an arbitrary ordered set of k sampling
times, and y ∈ ℜk is a real vector. The joint density at (y, t) of the values and the
survival time is
qt(y, t) = f(t)× (2π)
−k/2|Σ|−1/2 exp
(
−(y − γ)′Σ−1(y − γ)/2
)
, (8)
for t > max(t), and zero otherwise. Here, γ = µt[t] is the conditional mean func-
tion and Σ = Kt[t, t] is the conditional covariance function, both evaluated at the
sampling times.
The joint marginal density at y is obtained by a one-dimensional integral
pt(y) =
∫ ∞
0
qt(y, t) dt, (9)
which may be restricted to the range t > max(t). The dependence of the condi-
tional moments on t, means that this integral must be computed numerically. The
marginal density at any other point in Sk, for example an interval-censored record
with one or more trailing components of y equal to ♭, is obtained by integration of
(8) over a finite range.
The joint density function for all patients is a product of n factors, one factor
of type (8) for each uncensored record, and one factor of type (9) for each right-
censored record.
The state of affairs is only slightly more complicated if the process has more
than one absorbing state, which is also recorded at the time of death. In that case,
f is the joint distribution of time of death and the absorbing state, while qt(s) is
the conditional distribution of Y given the failure time and absorbing state. The
situation is considerably more complicated if Y has multiple components, including
non-vital components such as a time-evolving risk factor.
8.2 Parameter estimation
Suppose that the parameter vector can be partitioned into two components θ =
(λ, ψ), the first related to the distribution of survival times, and the second related
to the conditional distribution given the survival time. Both components contain
parameters related to covariate and treatment effects.
Let [n] = {1, . . . , n} be the set of records, and C ⊂ [n] the subset of censored
records. For an uncensored record, t is the survival time; for a censored record, t is
the censoring time. The joint density is a product of four factors:
∏
i∈C¯
qt(yi, ti; θ)
∏
i∈C
pt(yi; θ) =
∏
i∈C¯
f(ti;λ)
∏
i∈C
S(ti;λ)×
∏
i∈C¯
qt(yi, ti; θ)
f(ti;λ)
∏
i∈C
pt(yi; θ)
S(ti;λ)
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where f(t;λ) is the density function and S(t;λ) is the survivor function. The
marginal likelihood based on the observed survival and censoring times only, is the
product of the first two factors, which is a function of λ alone.
The third factor is the conditional distribution of Y given the failure times for
those patients who have been observed to fail. The ratio
∏
i∈C¯
qt(yi, ti; θ)
f(ti;λ)
,
is a standard Gaussian likelihood function depending only on ψ. The final term for
censored records is a function of both parameters.
This factorization is extremely convenient because it allows us to obtain consis-
tent estimates of both parameters in a simple manner using standard software for
survival analysis and standard software for Gaussian models, and to check various
aspects of the model formulation. In addition, by examining the fourth factor for
censored records alone, it is possible, and strongly advised, to check whether the
behaviour of the health process for censored records is compatible with that for
uncensored records.
After these preliminary calculations have identified a set of candidate models
for comparison, the joint likelihood function may be computed and maximized.
This last step, and only this step, requires specialized software for computing the
one-dimensional integral in (9).
Computational matters are beyond the scope of this paper, but details are pro-
vided in Dempsey and McCullagh (2016).
9 Time-evolving exposure
9.1 Statistically exogenous variable
Let (X,Y ) be a bivariate temporal process in which Y is purely vital, and X is
an exogenous exposure variable. As the term suggests, a vital variable is a health-
related response; an exogenous variable may be indirectly health-related, such as
an environmental exposure or risk factor. This terminology implies that the focus
of attention is on the behaviour of Y in response to X , suggesting that X drives Y
rather than vice-versa.
Let HXYt = H
X
t ⊗H
Y
t be the complete history of the joint process up to time t.
We say that X is statistically exogenous for patient health if the independent-
evolution condition
X ⊥ HYt | H
X
t
is satisfied for every t. An equivalent statement is that the conditional distribution
of health values up to time t given the entire trajectory of the exposure factor
depends only on past exposures. Roughly speaking, future exposure has no effect
on current or past health.
For the remainder of this section, X is statistically exogenous for Y .
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9.2 A special Gaussian process
One way to construct a joint survival process is to factor the joint density in the
obvious way:
p(X) · p(T | X) · p(Y | X,T ).
The first part is the marginal distribution of the exogenous process; the second is
the distribution of the survival time given the entire exposure trajectory, and the
third is the conditional distribution given X,T . Since X is statistically exogenous
by assumption, the conditional survivor function pr(T > t | X) is a function of the
past history only, and the third factor has a similar property.
Suppose first that Y = T˜ , so the third factor is degenerate. We ask only for a
joint distribution for (X,T ) in the sense of section 4, but with the additional require-
ment that X be exogenous. For definiteness let X ∼ GP(µ,K0) be a continuous-
time Gaussian process with mean µ and covariance function K0. This process
continues indefinitely in time, and may even be stationary. The second factor is the
conditional survival distribution, or the conditional hazard density at time t given
X , which, for simplicity, we take to be h(X(t)) dt, depending only on the current
exposure.
The preceding paragraph specifies the process but does not directly yield finite-
dimensional distributions of the type needed for likelihood calculations in statistical
work, where the exposure process is not observed continuously in time. For example,
the conditional distribution given X is not to be confused with the conditional
distribution given the recorded values of X . For a finite collection of k time points
t, the joint density qt(x, t) of the exposure values and the survival time at (x, t)
is the product of two factors. The first is the Gaussian density at x ∈ ℜk with
mean µ[t] and covariance K0[t, t], both evaluated at the indicated sampling points.
The second is the conditional survival density given X [t] = x, which is a Gaussian
integral
f(t | X [t]) = E
(
h(X(t)) exp
(
−
∫ t
0
h(X(s)) ds
) ∣∣∣ X [t]
)
, (10)
similar to that arising in (4) for a joint model. This is the contribution to the log
likelihood function for an uncensored record. In the case of a record censored at t,
the conditional density (10) is replaced by the conditional survivor function, which
requires an additional one-dimensional integral over survival times.
It is quite possible in this setting that t < max(t), so the exposure process is
measured post mortem, or possibly also pre-recruitment. In a medical sense, indi-
vidual health cannot be affected by post-mortem exposure, but the integral (10) is
affected, and the likelihood function also. In this respect, an external exposure pro-
cess is not equivalent to a time-varying covariate such as age or sex-age interaction,
which is known as a function of time.
These are the calculations needed to study the effect of a time-evolving exposure
factor on the distribution of survival times. Where additional health measurements
are involved, the likelihood function has a third factor. Suppose that Y is a Gaussian
health process of the type described in section 8, with conditional moments
E(Ys | X,T = t) = µ(s, t,X(s))
12
cov(Ys, Ys′ | X,T = t) =Kt(s, s
′)
for s, s′ < t. At this point, we have made the standard linear-model assumption
that the variance is constant and independent of treatment and exposure variables.
On account of the dependence of E(Ys) on the contemporaneous exposure X(s)
only, the third factor is a Gaussian density of the type discussed in section 8, which
requires no complicated integration. Otherwise, if E(Ys | X, t) were a non-trivial
function of past exposures at times other than those in t, it would be necessary to
compute a Gaussian conditional expected value as in (10).
For a record censored at t, it is necessary to integrate the triple product over
survival times, which is a one-dimensional integral. For this model at least, the
additional computations required to accommodate a sequence of health values is
relatively modest.
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